-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A growing body of research suggests that coronavirus disease (COVID-19) in 2019 can affect the heart.
recently, a study published in JAHA, an authoritative journal in the field of cardiovascular disease, looked at the clinical characteristics of COVID-19 patients and further identified risk factors for heart infection in COVID-19 patients.
the researchers analyzed data on 102 COVID-19 patients (52 women aged 19-87) who were laboratory-confirmed and hospitalized, and collected epidemiological and demographic characteristics, clinical characteristics, routine laboratory test results (including heart damage biomarkers), echo cardiac charts, electro electrograms, chest imaging results, treatments, and clinical outcomes.
, based on different levels of heart markers, the researchers divided patients into groups with acute heart injury (ACI) with or without abnormal heart markers.
In this study, 72 out of 102 patients (70.6%) had heart infection: tcardiocardial overspeed (n-20), electrocardiogram abnormalities (n-23), echocardiogram results abnormal (n-59), elevated cardiomyoenzyme (n-55) and acute cardiomyopathy (n-9).
8 ACI patients were aged 60 years, and 7 of them had two or more potential complications (hypertension, diabetes, cardiovascular disease, chronic obstructive pulmonary disease, and chronic kidney disease).
coronavirus pneumonia (NCP) in patients with ACI is much more severe than in patients with undecided ACI (p.lt;0.001).
multivariation analysis showed that C-reactive protein (CRP) levels, age, NCP severity and potential co-co-existing disorders were risk factors for heart infection in COVID-19 patients.
that it is common for patients with COVID-19 to suffer from heart disease.
increased CRP levels, old age, potential cocosis and NCP severity are the main risk factors for heart disease in COVID-19 patients.
to reduce mortality, more emphasis should be placed on cardiovascular protection during COVID-19 treatment.
.
